GlassScriptPhysician profile
Andrew Daniel Linkugel
NPI 1871013912
$6,452.71
in general payments reported to CMS, 2019-2025
17 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $763 · 2020: $758 · 2021: $2,286 · 2022: $858 · 2023: $918 · 2024: $698 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,314 · Travel and Lodging: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,313.81 |
| Travel and Lodging | $473.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,200.00 | 2021 | |
| Integra Lifesciences Corporation | $795.15 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Musculoskeletal Transplant Foundation INC. | $551.40 | 2021 | |
| Stryker Corporation | $497.83 | 2019-2023 | Vsp System, Vsp Cranial, Delta |
| Synthes Gmbh | $473.16 | 2024 | |
| Axogen | $451.32 | 2019-2021 | |
| Baxter Healthcare | $422.60 | 2019-2023 | Artiss |
| Depuy Synthes Sales INC. | $354.23 | 2023-2024 | Na, Trumatch, Matrixmandible |
| Kls-Martin L.P. | $332.17 | 2024-2025 | |
| Sientra, INC. | $312.28 | 2020-2021 | |
| Kci USA, INC. | $269.68 | 2019-2023 | Prevena Restor Bellaform, V.A.C. Veraflo, Prevena |
| Acera Surgical, INC. | $240.02 | 2020-2022 | |
| Polynovo North America LLC | $234.38 | 2021-2022 | |
| Acell, INC. | $90.19 | 2019 | |
| Zimmer Biomet Holdings, INC. | $89.26 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $71.47 | 2022 | |
| Misonix INC | $67.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Linkugel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.